CLINICAL_TRIALS
trial_result
· 2011-12-06
Clinical Trial Update: Incretins in Impaired Fasting Glucose [Phase 4]
Summary
Mayo Clinic conducted a Phase 4 trial evaluating incretin-based therapy in individuals with pre-diabetes, specifically impaired fasting glucose; the study has c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Pre-diabetes | Phase 4 | Status: COMPLETED | Results posted: 2011-12-06